Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Breast Neoplasms 92Polycystic Ovary Syndrome 10Neoplasm Metastasis 7Carcinoma, Ductal, Breast 5Infertility 4Carcinoma, Lobular 4Osteoporosis 3Neoplasms, Hormone-Dependent 3Neoplasms 3Breast Neoplasms, Male 3Advanced Breast Cancer 3Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Carcinoma In Situ 2Bone Diseases, Metabolic 2Unilateral Breast Neoplasms 1Recurrence 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Osteitis Deformans 1Obesity 1Neoplasms by Site 1Multiple Endocrine Neoplasia Type 1 1Low Grade Serous Ovarian Cancer 1Infertility, Female 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Hereditary Sensory and Autonomic Neuropathies 1Hereditary Breast and Ovarian Cancer Syndrome 1HR+/HER2- Breast Cancer 1HER2+ Breast Cancer 1

Interventions

Metformin 4Exenatide 2semaglutide 1lime 1dapagliflozin 1Taxes 1Tamoxifen 1Surveys and Questionnaires 1Sugars 1Sugammadex 1Sodium-Glucose Transporter 2 Inhibitors 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Qsymia 1Paclitaxel 1Liraglutide 1Letrozole 1Immunoenzyme Techniques 1Glucagon-Like Peptide 1 1Early Intervention, Educational 1Diazoxide 1Counseling 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Obesity × Letrozole × Clear all
NCT01758146 2020-03-04

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

Post Graduate Institute of Medical Education and Research, Chandigarh

Phase 3 Unknown
412 enrolled
BreastOther

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡